Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 187
interventional 160
Observational 24
Registry 3

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 65
Biological|Drug|Procedure 15
Drug|Other 13
Biological 9
Biological|Drug 8
Drug|Procedure 6
Procedure 5
Biological|Drug|Other 4
Drug|Other|Procedure 4
Drug|Procedure|Radiation 4
Behavioral 3
Drug|Radiation 3
Drug|placebo 2
Other 2
Other|Procedure 2
Procedure|Radiation 2
Behavioral|Drug 1
Behavioral|Other 1
Behavioral|Other|Procedure 1
Biological|Drug|Other|Procedure 1
Biological|Drug|Procedure|Radiation 1
Biological|Genetic|Other|Procedure 1
Biological|Other 1
Biological|Procedure 1
Device 1
Device|Drug 1
Diagnostic Test|Other 1
Drug|Genetic|Other|Procedure|Radiation 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 94
United Kingdom 9
United States|Puerto Rico 9
France 7
Slovakia 5
Italy 4
United States|Canada 4
Canada 3
Germany 3
United States|Australia|Canada|Netherlands|Puerto Rico|Switzerland 2
United States|Australia|Canada|Puerto Rico 2
Australia|New Zealand 1
Australia|United States|Belgium|Denmark|France|Germany|Ireland|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|France|Germany|Greece|Israel|Italy|Netherlands|Norway|Portugal|Spain|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|France|Germany|Netherlands|Norway|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|Germany|Italy|Netherlands|Norway|Poland|Slovakia|Spain|Switzerland|United Kingdom 1
Brazil|Canada|Finland|Netherlands|Norway|South Africa|United Kingdom 1
China 1
Ireland|United Kingdom 1
Korea, Republic of 1
United States|Australia|Canada 1
United States|Australia|Canada|Japan|New Zealand|Puerto Rico|Saudi Arabia 1
United States|Australia|Canada|New Zealand|Puerto Rico 1
United States|Australia|Canada|New Zealand|Switzerland 1
United States|Australia|Peru|Puerto Rico 1
United States|Belgium|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|United Kingdom 1
United States|France|Slovakia 1
United States|France|United Kingdom 1
United States|South Africa 1

Sites per Study

Site_count Study_Count
1 87
2 10
3 4
4 1
5 3
6 4
7 2
8 3
9 1
10 4
12 2
13 1
14 1
17 1
19 2
20 1
21 1
24 2
25 1
27 2
35 1
37 1
49 1
51 1
62 1
76 1
86 1
94 1
95 1
98 1
106 2
110 1
111 2
112 2
116 1
117 1
118 2
153 1
161 1
167 2
516 1
938 1

Phase

Phase Study_Count
Phase 2 79
Phase 1 36
N/A 16
Phase 3 15
Phase 1/Phase 2 13
Phase 4 1

Number of Arms

Number_of_Arms Count_of_Studies
1 77
2 27
3 3
4 1
5 2
12 1
NA 49

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.3 Phase.4
Min. 10.000 6.00000 26.00 8.00000 69.0000 250
1st Qu. 19.250 20.00000 32.50 25.00000 213.0000 250
Median 52.500 26.00000 51.50 43.00000 255.0000 250
Mean 5752.286 32.69697 116.10 98.05714 406.2143 250
3rd Qu. 375.500 38.00000 134.25 91.00000 480.0000 250
Max. 78216.000 108.00000 527.00 1500.00000 1680.0000 250

Trial Group Type

group_type Group_Count
Experimental 142
NA 49
Active Comparator 11
Other 7
No Intervention 4
Placebo Comparator 1
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 91
NA 41
Parallel Assignment 25
Crossover Assignment 2
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 133
Supportive Care 16
Diagnostic 5
Screening 2
NA 2
Health Services Research 1
Other 1

Observational Studies

Studies by Country

Country Study_Count
United States 12
Egypt 2
France 2
NA 2
Australia 1
Denmark 1
Singapore 1
United Kingdom 1
United States|Canada 1
United States|Canada|Puerto Rico|Switzerland 1

Sites per Study

Site_count Study_Count
1 13
2 1
3 2
7 1
9 1
16 1
22 1
31 1
66 1
182 1
187 1

Enrollment Metrics

Measure Observational
Min 6.0000
1st Qu 73.5000
Median 235.5000
Mean 641.3333
3rd Qu 938.0000
Max 4000.0000

Observation Model

observational_model Study_Count
Cohort 11
Case-Only 4
Case-Control 3
Family-Based 2
Other 2
NA 2

Time Perspective

time_perspective Study_Count
Prospective 11
Retrospective 10
NA 2
Other 1

Registries

Studies by Country

Country Study_Count
Brazil 1
China 1
United States 1

Sites per Study

Site_count Study_Count
1 2
4 1

Enrollment Metrics

Measure Registries
Min 30.000
1st Qu 765.000
Median 1500.000
Mean 1176.667
3rd Qu 1750.000
Max 2000.000

Registry Model

observational_model Study_Count
Cohort 2
Other 1

Time Perspective

time_perspective Study_Count
Prospective 2
Other 1

Follow-up

target_duration Study_Count
1 Year 2
16 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT01873326 Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors https://ClinicalTrials.gov/show/NCT01873326 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-06-30
NCT04195555 Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT04195555 Recruiting National Cancer Institute (NCI) 2025-12-31
NCT04035447 Symptom Management for YA Cancer Survivors https://ClinicalTrials.gov/show/NCT04035447 Recruiting Duke University 2025-10-01
NCT03698994 Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03698994 Recruiting National Cancer Institute (NCI) 2025-12-31
NCT03526250 Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03526250 Recruiting National Cancer Institute (NCI) 2025-06-30
NCT04222972 AcceleRET Lung Study of Pralsetinib for 1L RET Fusion-positive, Metastatic NSCLC https://ClinicalTrials.gov/show/NCT04222972 Recruiting Blueprint Medicines Corporation 2023-09-30
NCT03158064 Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors https://ClinicalTrials.gov/show/NCT03158064 Recruiting Memorial Sloan Kettering Cancer Center 2021-11-30
NCT03067181 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors https://ClinicalTrials.gov/show/NCT03067181 Recruiting Children’s Oncology Group 2027-06-30
NCT03037385 Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03037385 Recruiting Blueprint Medicines Corporation 2021-12-31
NCT03012620 Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types https://ClinicalTrials.gov/show/NCT03012620 Recruiting UNICANCER 2023-01-31
NCT03233204 Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03233204 Recruiting National Cancer Institute (NCI) 2024-09-30
NCT02875314 HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors https://ClinicalTrials.gov/show/NCT02875314 Recruiting Nationwide Children’s Hospital 2020-09-30
NCT02860819 Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer https://ClinicalTrials.gov/show/NCT02860819 Recruiting National Cancer Institute, Slovakia 2019-12-31
NCT02859415 Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases https://ClinicalTrials.gov/show/NCT02859415 Recruiting National Institutes of Health Clinical Center (CC) 2028-08-03
NCT03213704 Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03213704 Recruiting National Cancer Institute (NCI) 2024-09-30
NCT02797626 Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST) https://ClinicalTrials.gov/show/NCT02797626 Recruiting Heinrich-Heine University, Duesseldorf 2021-06-30
NCT02784054 Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor https://ClinicalTrials.gov/show/NCT02784054 Recruiting Samsung Medical Center 2021-03-31
NCT03213678 PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03213678 Recruiting National Cancer Institute (NCI) 2024-09-30
NCT03213665 Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03213665 Recruiting National Cancer Institute (NCI) 2024-09-30
NCT03213652 Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) https://ClinicalTrials.gov/show/NCT03213652 Recruiting National Cancer Institute (NCI) 2024-09-30
NCT02582697 Accelerated v’s Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours https://ClinicalTrials.gov/show/NCT02582697 Recruiting University of Sydney 2022-02-28
NCT03155620 Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) https://ClinicalTrials.gov/show/NCT03155620 Recruiting National Cancer Institute (NCI) 2027-09-30
NCT03403777 Avelumab in Refractory Testicular Germ Cell Cancer. https://ClinicalTrials.gov/show/NCT03403777 Completed National Cancer Institute, Slovakia 2019-02-28
NCT02536183 A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT02536183 Recruiting Children’s National Research Institute 2020-10-31
NCT02533765 Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor https://ClinicalTrials.gov/show/NCT02533765 Active, not recruiting Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori 2018-09-30
NCT02429687 TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors https://ClinicalTrials.gov/show/NCT02429687 Recruiting Shandong University 2021-05-31
NCT02429466 Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors https://ClinicalTrials.gov/show/NCT02429466 Active, not recruiting Indiana University 2018-12-31
NCT02414685 First Line TIP in Poor Prognosis TGCTs. https://ClinicalTrials.gov/show/NCT02414685 Recruiting National Cancer Institute, Slovakia 2019-12-31
NCT02375204 Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors https://ClinicalTrials.gov/show/NCT02375204 Recruiting Alliance for Clinical Trials in Oncology 2024-06-30
NCT02340884 A Pilot RCT of the PRISM Intervention for AYAs With Cancer https://ClinicalTrials.gov/show/NCT02340884 Active, not recruiting Seattle Children’s Hospital 2017-09-19
NCT02317393 Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy https://ClinicalTrials.gov/show/NCT02317393 Recruiting Centre Francois Baclesse 2020-03-31
NCT02161692 Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors https://ClinicalTrials.gov/show/NCT02161692 Completed Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2007-05-31
NCT02122185 Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer https://ClinicalTrials.gov/show/NCT02122185 Recruiting University of Chicago 2021-02-25
NCT02104986 A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent https://ClinicalTrials.gov/show/NCT02104986 Recruiting Centre Leon Berard 2021-05-31
NCT02095132 Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT02095132 Active, not recruiting National Cancer Institute (NCI) 2021-04-30
NCT02076906 MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors https://ClinicalTrials.gov/show/NCT02076906 Recruiting Children’s National Research Institute 2020-10-31
NCT01270724 Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) https://ClinicalTrials.gov/show/NCT01270724 Completed Nationwide Children’s Hospital 2019-10-23
NCT01966913 Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors https://ClinicalTrials.gov/show/NCT01966913 Recruiting Assistance Publique - Hôpitaux de Paris 2019-03-31
NCT01851200 Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors https://ClinicalTrials.gov/show/NCT01851200 Completed Fondazione Michelangelo 2017-08-31
NCT01846520 Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers https://ClinicalTrials.gov/show/NCT01846520 Completed City of Hope Medical Center 2019-05-23
NCT01782339 A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis https://ClinicalTrials.gov/show/NCT01782339 Recruiting Barts & The London NHS Trust 2021-01-31
NCT01764802 Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer https://ClinicalTrials.gov/show/NCT01764802 Completed Ohio State University Comprehensive Cancer Center 2017-06-01
NCT01736917 Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors https://ClinicalTrials.gov/show/NCT01736917 Completed Hoosier Cancer Research Network 2015-03-31
NCT01726374 Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours https://ClinicalTrials.gov/show/NCT01726374 Active, not recruiting Institute of Cancer Research, United Kingdom 2016-08-31
NCT01696994 Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) https://ClinicalTrials.gov/show/NCT01696994 Active, not recruiting National Cancer Institute (NCI) 2012-05-21
NCT01602666 Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors https://ClinicalTrials.gov/show/NCT01602666 Active, not recruiting Children’s Oncology Group 2019-09-30
NCT01484015 Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT01484015 Completed Wake Forest University Health Sciences 2012-06-30
NCT01466231 Everolimus in Refractory Testicular Germ Cell Cancer https://ClinicalTrials.gov/show/NCT01466231 Completed National Cancer Institute, Slovakia 2015-06-30
NCT01322802 Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer https://ClinicalTrials.gov/show/NCT01322802 Active, not recruiting University of Washington 2015-01-09
NCT04402593 Music Therapy For The Treatment Of Cisplatin Induced Tinnitus In Patients With rGCC: A Pilot Study https://ClinicalTrials.gov/show/NCT04402593 Active, not recruiting Indiana University 2021-12-31
NCT03950830 Disulfiram and Cisplatin in Refractory TGCTs. https://ClinicalTrials.gov/show/NCT03950830 Recruiting National Cancer Institute, Slovakia 2021-12-31
NCT03760081 A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors https://ClinicalTrials.gov/show/NCT03760081 Recruiting Astellas Pharma Inc 2022-09-30
NCT03434262 SJDAWN: St. Jude Children’s Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors https://ClinicalTrials.gov/show/NCT03434262 Recruiting St. Jude Children’s Research Hospital 2025-02-28
NCT03426865 Role of Axumin PET Scan in Germ Cell Tumor https://ClinicalTrials.gov/show/NCT03426865 Completed University of Texas Southwestern Medical Center 2019-12-30
NCT03418844 Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy https://ClinicalTrials.gov/show/NCT03418844 Recruiting Centre Francois Baclesse 2020-06-30
NCT01242631 Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer https://ClinicalTrials.gov/show/NCT01242631 Completed Hannover Medical School 2014-03-31
NCT01155258 Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT01155258 Completed University of Southern California 2013-01-31
NCT01131234 Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT01131234 Completed National Cancer Institute (NCI) 2014-09-30
NCT01126346 Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) https://ClinicalTrials.gov/show/NCT01126346 Completed Wake Forest University Health Sciences 2011-04-30
NCT01079832 Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies https://ClinicalTrials.gov/show/NCT01079832 Completed Case Comprehensive Cancer Center 2012-05-31
NCT01076530 Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors https://ClinicalTrials.gov/show/NCT01076530 Completed National Cancer Institute (NCI) 2012-10-31
NCT01055067 ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors https://ClinicalTrials.gov/show/NCT01055067 Completed Daiichi Sankyo, Inc. 2011-11-30
NCT01049230 Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors https://ClinicalTrials.gov/show/NCT01049230 Active, not recruiting Massachusetts General Hospital 2020-03-31
NCT01037790 PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER https://ClinicalTrials.gov/show/NCT01037790 Completed Abramson Cancer Center of the University of Pennsylvania 2019-10-31
NCT00994500 Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma https://ClinicalTrials.gov/show/NCT00994500 Completed National Cancer Institute (NCI) 2011-07-31
NCT00957905 Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00957905 Completed National Cancer Institute (NCI) 2014-08-31
NCT00936936 High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors https://ClinicalTrials.gov/show/NCT00936936 Active, not recruiting M.D. Anderson Cancer Center 2020-10-15
NCT00929903 Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment https://ClinicalTrials.gov/show/NCT00929903 Completed National Cancer Institute (NCI) 2013-04-30
NCT00864318 Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis https://ClinicalTrials.gov/show/NCT00864318 Active, not recruiting Institut Claudius Regaud 2021-09-30
NCT03911388 HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors https://ClinicalTrials.gov/show/NCT03911388 Recruiting University of Alabama at Birmingham 2023-09-01
NCT03081923 Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors https://ClinicalTrials.gov/show/NCT03081923 Recruiting Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2019-12-31
NCT02834013 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors https://ClinicalTrials.gov/show/NCT02834013 Recruiting National Cancer Institute (NCI) 2021-08-31
NCT00788125 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors https://ClinicalTrials.gov/show/NCT00788125 Active, not recruiting City of Hope Medical Center 2023-09-30
NCT00716976 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy https://ClinicalTrials.gov/show/NCT00716976 Completed Children’s Oncology Group 2015-04-30
NCT00638898 Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor https://ClinicalTrials.gov/show/NCT00638898 Active, not recruiting City of Hope Medical Center 2020-09-01
NCT00611962 Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin https://ClinicalTrials.gov/show/NCT00611962 Completed Sanofi NA
NCT00572572 Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00572572 Completed Hoosier Cancer Research Network 2010-12-31
NCT00470366 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00470366 Completed Memorial Sloan Kettering Cancer Center 2016-06-30
NCT00467051 Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00467051 Completed Children’s Oncology Group 2012-03-01
NCT00453310 Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment https://ClinicalTrials.gov/show/NCT00453310 Completed Memorial Sloan Kettering Cancer Center 2008-11-30
NCT00453232 Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00453232 Completed National Cancer Institute (NCI) 2008-12-31
NCT00019578 Stereotactic Radiosurgery in Treating Patients With Brain Tumors https://ClinicalTrials.gov/show/NCT00019578 Completed National Institutes of Health Clinical Center (CC) NA
NCT00436254 Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer https://ClinicalTrials.gov/show/NCT00436254 Active, not recruiting University of Washington 2010-03-31
NCT00432094 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00432094 Recruiting Masonic Cancer Center, University of Minnesota 2020-08-31
NCT00423852 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin https://ClinicalTrials.gov/show/NCT00423852 Completed Memorial Sloan Kettering Cancer Center 2013-02-28
NCT00410657 Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00410657 Completed Fred Hutchinson Cancer Research Center 2006-11-30
NCT00408681 Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00408681 Completed Fred Hutchinson Cancer Research Center 2010-11-30
NCT00408655 Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00408655 Completed National Cancer Institute (NCI) 2012-01-31
NCT00393861 Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients https://ClinicalTrials.gov/show/NCT00393861 Completed Indiana University 2012-10-31
NCT00387920 Sunitinib in Treating Young Patients With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00387920 Completed National Cancer Institute (NCI) 2012-09-30
NCT00371553 Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer https://ClinicalTrials.gov/show/NCT00371553 Completed British Columbia Cancer Agency 2009-06-30
NCT00324298 Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles https://ClinicalTrials.gov/show/NCT00324298 Completed National Cancer Institute (NCI) NA
NCT00313599 Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00313599 Completed University of California, San Francisco 2013-12-31
NCT00303940 Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors https://ClinicalTrials.gov/show/NCT00303940 Completed National Institutes of Health Clinical Center (CC) NA
NCT00301782 Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00301782 Completed National Cancer Institute (NCI) NA
NCT00293384 Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00293384 Completed Barbara Ann Karmanos Cancer Institute 2009-06-30
NCT00293358 Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain https://ClinicalTrials.gov/show/NCT00293358 Completed National Cancer Institute (NCI) NA
NCT00281944 Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00281944 Completed National Cancer Institute (NCI) 2009-05-31
NCT00228358 Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient’s Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine https://ClinicalTrials.gov/show/NCT00228358 Completed University of Washington 2011-05-31
NCT00204633 Darbepoetin Alfa in Patients With “Poor Prognosis” Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) https://ClinicalTrials.gov/show/NCT00204633 Completed University Hospital Tuebingen 2008-12-31
NCT00187109 Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy https://ClinicalTrials.gov/show/NCT00187109 Completed St. Jude Children’s Research Hospital 2007-02-28
NCT00183820 Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma https://ClinicalTrials.gov/show/NCT00183820 Completed University of Southern California 2015-12-31
NCT00109993 Campath-1H + FK506 and Methylprednisolone for GVHD https://ClinicalTrials.gov/show/NCT00109993 Completed Case Comprehensive Cancer Center 2006-06-30
NCT00104676 Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00104676 Active, not recruiting UNICANCER 2012-03-29
NCT00101270 Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00101270 Completed National Cancer Institute (NCI) 2007-09-30
NCT00091182 Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment https://ClinicalTrials.gov/show/NCT00091182 Completed National Cancer Institute (NCI) 2006-02-28
NCT00002489 Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00002489 Completed Memorial Sloan Kettering Cancer Center 2002-06-30
NCT00003982 MEN-10755 in Treating Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT00003982 Completed European Organisation for Research and Treatment of Cancer - EORTC NA
NCT00003518 Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00003518 Completed Eastern Cooperative Oncology Group 2002-07-31
NCT00002750 Melphalan in Patients With Neoplastic Meningitis https://ClinicalTrials.gov/show/NCT00002750 Completed Duke University 2001-05-31
NCT00082654 Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients https://ClinicalTrials.gov/show/NCT00082654 Completed Fred Hutchinson Cancer Research Center 2004-10-31
NCT00002903 Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer https://ClinicalTrials.gov/show/NCT00002903 Completed European Organisation for Research and Treatment of Cancer - EORTC NA
NCT00004604 Biological Therapy in Treating Patients With Metastatic Cancer https://ClinicalTrials.gov/show/NCT00004604 Completed Duke University 2001-06-30
NCT00003887 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00003887 Completed Fred Hutchinson Cancer Research Center NA
NCT00010283 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon https://ClinicalTrials.gov/show/NCT00010283 Completed Fred Hutchinson Cancer Research Center 2002-07-31
NCT00003107 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors https://ClinicalTrials.gov/show/NCT00003107 Completed Indiana University NA
NCT00007813 Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors https://ClinicalTrials.gov/show/NCT00007813 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2005-02-01
NCT00006043 Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin https://ClinicalTrials.gov/show/NCT00006043 Completed Memorial Sloan Kettering Cancer Center 2001-11-30
NCT00003657 High-dose ICE With Amifostine https://ClinicalTrials.gov/show/NCT00003657 Completed Dana-Farber Cancer Institute 2000-11-30
NCT00003014 Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer https://ClinicalTrials.gov/show/NCT00003014 Completed National Cancer Institute (NCI) NA
NCT00002508 Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00002508 Completed Temple University 2001-09-30
NCT00004157 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin’s Lymphoma, Hodgkin’s Disease, Breast Cancer, or Other Solid Tumors https://ClinicalTrials.gov/show/NCT00004157 Completed Fred Hutchinson Cancer Research Center 2002-04-30
NCT00003811 Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00003811 Completed Children’s Oncology Group 2004-10-31
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00070096 Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00070096 Completed National Cancer Institute (NCI) NA
NCT00002559 Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin https://ClinicalTrials.gov/show/NCT00002559 Completed Memorial Sloan Kettering Cancer Center 2003-01-31
NCT00002520 Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer https://ClinicalTrials.gov/show/NCT00002520 Completed Eastern Cooperative Oncology Group 2002-02-28
NCT00066482 Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00066482 Completed Children’s Oncology Group 2007-04-30
NCT00064311 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00064311 Completed National Institutes of Health Clinical Center (CC) NA
NCT00003408 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer https://ClinicalTrials.gov/show/NCT00003408 Completed National Cancer Institute (NCI) NA
NCT00060255 High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors https://ClinicalTrials.gov/show/NCT00060255 Completed Roswell Park Cancer Institute 2006-08-31
NCT00003173 High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00003173 Completed Memorial Sloan Kettering Cancer Center 2003-05-31
NCT00047320 Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00047320 Completed Children’s Oncology Group 2009-02-28
NCT00045045 Positron Emission Tomography in Detecting Testicle Cancer https://ClinicalTrials.gov/show/NCT00045045 Completed National Cancer Institute (NCI) NA
NCT00040911 Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT00040911 Completed Children’s Oncology Group 2009-10-31
NCT00036959 ABT-751 in Treating Young Patients With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00036959 Completed National Institutes of Health Clinical Center (CC) 2010-02-28
NCT00036842 Arsenic Trioxide in Treating Men With Germ Cell Cancer https://ClinicalTrials.gov/show/NCT00036842 Completed National Cancer Institute (NCI) NA
NCT00795769 Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00795769 Completed Fred Hutchinson Cancer Research Center 2009-06-09
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00028496 Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00028496 Completed National Cancer Institute (NCI) 2005-11-30
NCT00024258 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors https://ClinicalTrials.gov/show/NCT00024258 Completed Memorial Sloan Kettering Cancer Center 2009-05-31
NCT00020150 Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors https://ClinicalTrials.gov/show/NCT00020150 Completed National Cancer Institute (NCI) NA
NCT00019331 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT00019331 Completed National Cancer Institute (NCI) NA
NCT00006246 Busulfan in Treating Children and Adolescents With Refractory CNS Cancer https://ClinicalTrials.gov/show/NCT00006246 Completed Pediatric Brain Tumor Consortium 2003-05-31
NCT00005952 Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors https://ClinicalTrials.gov/show/NCT00005952 Completed Duke University 2005-11-30
NCT00005590 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00005590 Completed National Cancer Institute (NCI) NA
NCT00004077 Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer https://ClinicalTrials.gov/show/NCT00004077 Completed National Cancer Institute (NCI) NA
NCT00003941 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer https://ClinicalTrials.gov/show/NCT00003941 Completed European Organisation for Research and Treatment of Cancer - EORTC 2007-06-30
NCT00003800 Diagnostic Study of Patients With Stage I Testicular Cancer https://ClinicalTrials.gov/show/NCT00003800 Completed Eastern Cooperative Oncology Group 2004-12-31
NCT00003420 CT Scans in Treating Patients With Stage I Testicular Cancer After Undergoing Orchiectomy https://ClinicalTrials.gov/show/NCT00003420 Completed National Cancer Institute (NCI) NA
NCT00002943 Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer https://ClinicalTrials.gov/show/NCT00002943 Completed Wake Forest University Health Sciences 2003-10-31
NCT00002931 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer https://ClinicalTrials.gov/show/NCT00002931 Completed City of Hope Medical Center 2014-12-31
NCT00002596 Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00002596 Completed National Cancer Institute (NCI) NA
NCT00002594 Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00002594 Completed Children’s Oncology Group 2003-09-30
NCT00002558 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00002558 Completed Memorial Sloan Kettering Cancer Center 2009-04-30
NCT00002515 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer https://ClinicalTrials.gov/show/NCT00002515 Completed Memorial Sloan Kettering Cancer Center 2005-04-30
NCT00002472 Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors https://ClinicalTrials.gov/show/NCT00002472 Completed Mayo Clinic 2005-08-31
NCT00030108 Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven’t Responded to Therapy https://ClinicalTrials.gov/show/NCT00030108 Completed National Institutes of Health Clinical Center (CC) 2010-03-31
NCT00060372 Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer https://ClinicalTrials.gov/show/NCT00060372 Completed National Cancer Institute (NCI) 2008-04-30
NCT00027534 Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00027534 Completed Duke University 2007-10-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04435756 A Study of miRNA 371 in Patients With Germ Cell Tumors https://ClinicalTrials.gov/show/NCT04435756 Recruiting Southwest Oncology Group 2025-04-01
NCT02679950 Understanding the Molecular and Genetic Differences Between Germ Cell Tumor at the Time of the Initial Diagnosis and at Late Relapse https://ClinicalTrials.gov/show/NCT02679950 Completed Indiana University 2017-04-25
NCT02677727 Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor https://ClinicalTrials.gov/show/NCT02677727 Active, not recruiting Indiana University 2020-07-26
NCT02665676 Embryonal Tumors of Infancy & Childhood: South Egypt Cancer Institute Experience https://ClinicalTrials.gov/show/NCT02665676 Recruiting Assiut University 2020-03-31
NCT00341588 A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen https://ClinicalTrials.gov/show/NCT00341588 Completed National Institutes of Health Clinical Center (CC) NA
NCT02303015 Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors https://ClinicalTrials.gov/show/NCT02303015 Recruiting Rigshospitalet, Denmark 2025-03-31
NCT02109926 A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures and the Risk of Testicular Germ Cell Tumor https://ClinicalTrials.gov/show/NCT02109926 Completed Centre Leon Berard 2018-03-30
NCT02099734 Germ Cell Tumor and Testicular Tumor DNA Registry https://ClinicalTrials.gov/show/NCT02099734 Recruiting Memorial Sloan Kettering Cancer Center 2021-01-31
NCT01572467 Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors https://ClinicalTrials.gov/show/NCT01572467 Completed Children’s Oncology Group 2016-07-31
NCT01453660 Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls https://ClinicalTrials.gov/show/NCT01453660 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-10-31
NCT01434355 DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings https://ClinicalTrials.gov/show/NCT01434355 Completed Children’s Oncology Group 2016-08-04
NCT01433224 Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression https://ClinicalTrials.gov/show/NCT01433224 Completed Children’s Oncology Group 2016-05-31
NCT04283773 Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors. https://ClinicalTrials.gov/show/NCT04283773 Recruiting Assiut University 2021-04-30
NCT04122430 Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours - a Multi-Site Retrospective Cohort Study as Part of the Global Germ-Cell Cancer Group (G3) Consortium https://ClinicalTrials.gov/show/NCT04122430 Active, not recruiting Walter and Eliza Hall Institute of Medical Research 2019-12-31
NCT03980587 Exploratory Study of Molecular Characterization in Patients With Metastatic Germ Cell Tumours Refractory/Resistant to Platinum Treatment https://ClinicalTrials.gov/show/NCT03980587 Recruiting Royal Marsden NHS Foundation Trust 2020-03-31
NCT03868176 Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell Tumors https://ClinicalTrials.gov/show/NCT03868176 Recruiting Centre Hospitalier Universitaire de Besancon 2021-08-31
NCT03860376 Ex Vivo Drug Sensitivity Testing and Mutation Profiling https://ClinicalTrials.gov/show/NCT03860376 Recruiting Florida International University 2022-12-15
NCT03476070 Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS) https://ClinicalTrials.gov/show/NCT03476070 Recruiting National University, Singapore 2021-05-01
NCT01080521 Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT01080521 Completed Gynecologic Oncology Group 2012-01-31
NCT00996710 Genomic Structural Variation in Cancer Susceptibility https://ClinicalTrials.gov/show/NCT00996710 Enrolling by invitation Memorial Sloan Kettering Cancer Center 2020-10-31
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898755 Completed Children’s Oncology Group 2008-07-17
NCT00897442 Collecting Tumor Samples From Patients With Gynecological Tumors https://ClinicalTrials.gov/show/NCT00897442 Completed Gynecologic Oncology Group 2016-01-31
NCT00002485 Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer https://ClinicalTrials.gov/show/NCT00002485 Completed Children’s Oncology Group 2003-07-31
NCT00010114 Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children https://ClinicalTrials.gov/show/NCT00010114 Completed Pediatric Brain Tumor Consortium 2003-03-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02863003 Multicenter Database of Patients With Germ Cell Tumor https://ClinicalTrials.gov/show/NCT02863003 Recruiting Latin American Cooperative Oncology Group 2020-12-31
NCT01890486 The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen https://ClinicalTrials.gov/show/NCT01890486 Recruiting Wake Forest University Health Sciences 2023-05-31
NCT03771625 Evaluating Structural and Functional Changes of Brain by fMRI and DTI in Patients With Intracranial Germ Cell Tumors https://ClinicalTrials.gov/show/NCT03771625 Recruiting Beijing Neurosurgical Institute 2021-06-01